Entries by Dana Fowlkes

October 14, 2014:

FORGE Life Science receives JumpStart Award announced at PA BIO Life Sciences Futures annual meeting in Philadelphia, PA. Read more 

September 2014:

FORGE Life Science featured in the Innovator’s Corner of PharmaVoice magazine. Read more

August 1, 2014:

Dr. Stacy Remiszewski, former Director of Chemistry, Section Head for Oncology Chemistry at Hoffmann-La Roche, joins FORGE Life Science as Head Of Chemistry.

June 4, 2014:

FORGE Life Science LLC is awarded a second grant from the NIH National Institute for Allergy and Infectious Disease titled, “A Single Antiviral to Treat Multiple Opportunistic Infections” (1R43AI114079-01). Read more

February 5, 2014:

FORGE Life Science LLC grant titled, “Host-Targeted Mechanism of Action for Treatment of Seasonal and Pandemic Influenza”, is awarded by the NIH National Institute for Allergy and Infectious Diseases (1R43AI110048-01). Read more

January 28, 2014:

FORGE Life Science LLC exclusively licenses Sirtuin-Antiviral Technology from Princeton University.

January 14, 2013:

FORGE Life Science LLC leases BSL2+ facilities from the Pennsylvania Biotechnology Center.